Protein N-myristoylation refers to the covalent attachment of a myristoyl group (C14:0), via amide linkage, to the NH2-terminal glycine residue of certain cellular and viral proteins. Myristoyl-CoA:protein N-myristoyltransferase (NMT) catalyzes this cotranslational modification. We have developed a system for studying the substrate requirements and biological effects of protein N-myristoylation as well as NMT structure-activit relationships. Expression of the yeast NMT1 gene in Escherchia cofi, a bacterium that has no endogenous NMT activity, results in production of the intact 53-kDa NMT polypeptide as well as a truncated polypeptide derived from proteolytic removal of its NH2-terminal 39 amino acids. Each E. coli-synthesized NMT species has fatty acid and peptide substrate specificities that are indistinguishable from those of NMT recovered from Saccharomyces cerevisiae, suggesting that the NH2-terminal domain of this enzyme is not required for its catalytic activity. By using a dual plasmid system, N-myristoylation of a mammalian protein was reconstituted inE. coliby simultaneous expression ofthe yeastNMT1 gene and a murine cDNA encoding the catalytic (C) subunit of cAMP-dependent protein kinase (PK-A). The fatty acid specificity of N-myristoylation was preserved in this system: [9,10(n)-3H]myristate but not [9,10(n)3H~palmitate was efficiently linked to Gly-1 of the C subunit. [13,14(n)-3HJ10-Propoxydecanoic acid, a heteroatom-containing analog of myristic acid with reduced hydrophobicity but similar chain length, was an effective alternative substrate for NMT that also could be incorporated into the C subunit of PK-A. Such Cotranslational (1) covalent attachment of myristic acid (C14:0) to the NH2-terminal glycine residue of a variety of cellular and viral proteins is, in many instances, required for full expression of their biological activity (reviewed in refs. 2 and 3). Current approaches to understanding the contribution of N-myristoylation to protein structure and function have involved site-directed mutagenesis of the NH2-terminal glycine to prevent acylation or the incorporation of heteroatomcontaining analogs of myristic acid with reduced hydrophobicity into N-myristoylated proteins in vivo (4). For example, abolishing myristoylation of the tyrosine kinase p6Ov-src by deletion of its Gly-1 residue or by Gly-1 -+ Ala substitution revealed (5, 6) that the C14:0 fatty acid is required for the protein's stable association with the plasma membrane (probably through interaction with a high-affinity myristoyl-src receptor; refs. 7 and 8) and its ability to transform cells. Analogous mutagenesis of the Gly-1 residues of the Moloney murine leukemia virus Pr65g (9), the Mason-Pfizer monkey virus Pr7859 (10), and the Pr55n of human immunodeficiency virus I (11) blocks viral replication. X-ray crystallographic studies (12) and site-directed mutagenesis (13) of the N-myristoylated poliovirus capsid protein VP4 have also indicated that myristic acid is involved in protein-protein interactions and in viral capsid protein assembly.
endogenous NMT activity, results in production of the intact 53-kDa NMT polypeptide as well as a truncated polypeptide derived from proteolytic removal of its NH2-terminal 39 amino acids. Each E. coli-synthesized NMT species has fatty acid and peptide substrate specificities that are indistinguishable from those of NMT recovered from Saccharomyces cerevisiae, suggesting that the NH2-terminal domain of this enzyme is not required for its catalytic activity. By using a dual plasmid system, N-myristoylation of a mammalian protein was reconstituted inE. coliby simultaneous expression ofthe yeastNMT1 gene and a murine cDNA encoding the catalytic (C) subunit of cAMP-dependent protein kinase (PK-A). The fatty acid specificity of N-myristoylation was preserved in this system: [9,10(n)-3H]myristate but not [9,10(n) 3H~palmitate was efficiently linked to Gly-1 of the C subunit. [13, 14 (n)-3HJ10-Propoxydecanoic acid, a heteroatom-containing analog of myristic acid with reduced hydrophobicity but similar chain length, was an effective alternative substrate for NMT that also could be incorporated into the C subunit of PK-A. Such analogs have recently been shown to inhibit replication of certain retroviruses that depend upon linkage of a myristoyl group to their gag polyprotein precursors (e.g., the Pr55P9 of human immunodeficiency virus type 1). A major advantage of the bacterial system over eukaryotic systems is the absence of endogenous NMT and substrates, providing a more straightforward way of preparing myristoylated, analog-substituted, and nonmyristoylated forms of a given protein for comparison of their structural and functional properties. The system should facilitate screening of enzyme inhibitors as well as alternative NMoT fatty add substrates for their ability to be incorporated into a specific target protein. Our experimental system may prove useful for recapitulating other eukaryotic protein modifications in E. coil so that structure-activity relationships of modifying enzymes and their substrates can be more readily assessed.
Cotranslational (1) covalent attachment of myristic acid (C14:0) to the NH2-terminal glycine residue of a variety of cellular and viral proteins is, in many instances, required for full expression of their biological activity (reviewed in refs. 2 and 3). Current approaches to understanding the contribution of N-myristoylation to protein structure and function have involved site-directed mutagenesis of the NH2-terminal glycine to prevent acylation or the incorporation of heteroatomcontaining analogs of myristic acid with reduced hydrophobicity into N-myristoylated proteins in vivo (4) . For example, abolishing myristoylation of the tyrosine kinase p6Ov-src by deletion of its Gly-1 residue or by Gly-1 -+ Ala substitution revealed (5, 6 ) that the C14:0 fatty acid is required for the protein's stable association with the plasma membrane (probably through interaction with a high-affinity myristoyl-src receptor; refs. 7 and 8) and its ability to transform cells. Analogous mutagenesis of the Gly-1 residues of the Moloney murine leukemia virus Pr65g (9) , the Mason-Pfizer monkey virus Pr7859 (10) , and the Pr55n of human immunodeficiency virus I (11) blocks viral replication. X-ray crystallographic studies (12) and site-directed mutagenesis (13) of the N-myristoylated poliovirus capsid protein VP4 have also indicated that myristic acid is involved in protein-protein interactions and in viral capsid protein assembly.
We have used an in vitro assay system to study the substrate specificity of myristoyl-CoA:protein N-myristoyltransferase (NMT; E.C. 2.3.1.97) from yeast and mammalian cells (14) (15) (16) . Detailed analyses of Saccharomyces cerevisiae NMT using octapeptide substrates and naturally occurring acyl-CoAs of different chain lengths revealed that the high degree of selectivity of the enzyme for myristoyl-CoA arises from an apparent cooperativity between its acyl-CoA and peptide binding sites. When acyl-CoAs of "incorrect" chain length are bound by NMT, dramatic reductions occur in the enzyme's affinity for peptide substrates, thus preventing generation of acyl-peptides (16) . These studies also showed that the acyl-CoA and peptide substrate specificities of NMTs from species as diverse as yeast and mammals are highly conserved (15) .
Substitution of an oxygen or sulfur for a methylene group in the hydrocarbon chain of myristic acid produces substantial reductions in hydrophobicity (equivalent to the loss of two to four methylene groups) without affecting chain length (16) . In vitro studies (16) Fig. la) . This was accomplished by ligating the newly generated 1.9-kb Nco I-HindIII fragment into Nco I/HindIII-digested pMON5840, a derivative of pMON5515 (20) . The resulting plasmid (pBB125) was used to transform E. coli strain JM101. Transformants were shaken at 37°C in LB broth containing 100 ,ug of ampicillin per ml to an OD6w of 1.0. The recA promoter was induced by adding nalidixic acid to a final concentration of 50 ,ug/ml (21 In Vitro Assay System for NMT Activity. To assess the peptide and acyl-CoA substrate specificities of E. coliderived S. cerevisiae NMT, crude lysates or partially purified enzyme preparations were added to a coupled in vitro assay system (16 (18) . A six-step 11,000-fold purification involving the use of four different chromatographic matrices was required to obtain an apparently homogeneous preparation of enzyme from this yeast (14) . E. coli lysates contain no detectable NMT activity as judged by a sensitive in vitro assay (16) for the enzyme (data not shown). Thus, expression of yeast NMT in the prokaryote offers an opportunity to obtain large quantities of wild-type (or mutant) protein whose activity can be measured in the absence of any endogenous myristoyltransferases.
The expression of S. cerevisiae NMT in E. coli was achieved by using pMON plasmid vectors. These vectors contain inducible promotors fused to a translational "enhancer" derived from the gene 10 leader region (glO-L) of bacteriophage T7 (20) . The yeast NMTJ gene was cloned immediately downstream of glO-L, and its transcription was controlled with the E. coli recA promoter located 5' to gJO-L.
E. coli strain JM101 carrying this recombinant plasmid was grown to mid-logarithmic phase and then treated with nalidixic acid to induce the recA promoter. NMT was subsequently purified -750-fold by sequential ammonium sulfate fractionation, DEAE-Sepharose CL-6B, and CoA-agarose affinity column chromatography of induced cell lysates (14) . The partially purified E. coli-derived yeast NMT displayed Km and Vmax values for a variety of octapeptide substrates that were nearly identical to those measured with a partially purified NMT preparation from S. cerevisiae (Table 1) . For example, introduction of a serine residue at position 5 of a "parental" octapeptide, GNAAAARR-NH2, obtained from the NH2-terminal sequence of the C subunit of PK-A reduces its apparent Kmby a factor of >100 for both NMT preparations. An NH2-terminal glycine is absolutely required. Substitution ofan Ala-1for the Gly-1 residue converts the peptide into an inactive substrate. Addition of an NH2-terminal methionine residue also generates an inactive peptide, indi- (14) , has no associated methionylaminopeptidase activity.
To verify that E. coli was producing an intact yeast NMT, proteins eluted from the CoA-agarose column with 100 mM KCl were separated by SDS/PAGE and transferred to a polyvinylidene difluoride membrane. An =53-kDa polypeptide, which corresponds to the mass of the 455-residue yeast NMT (18) , was excised from this membrane and subjected to Edman degradation. The NH2-terminal sequence indicated that the 53-kDa polypeptide represented intact yeast NMT (data not shown).
To obtain a homogenous preparation of the enzyme, E. coli-produced NMT was further purified by Mono S fast protein liquid chromatography (FPLC). Coomassie blue staining of SDS/PAGE gels of the 250 mM NaCl eluate from a Mono S column (14) revealed an additional band of %'45 kDa, which coeluted with NMT catalytic activity. Edman degradation of the 45-kDa polypeptide revealed that it was missing the NH2-terminal 39 residues of NMT, suggesting that portions of the polypeptide chain, such as the bond between Lys-39 and Phe-40, are susceptible to proteolysis and rapidly lost either during purification or shortly after synthesis in E. coli.
The Mono S-purified 45-kDa NMT species retained the ability to readily distinguish between myristoyl-CoA and palmitoyl-CoA and displayed the reduction by 100 in apparent Km for Ser-5-substituted GNAAAARR-NH2 (Table 1) . Therefore, the 45-kDa proteolytic fragment retains the core catalytic domain. The role of the missing 39 amino acids remains unknown, but they may be needed for (essential) interactions of NMT with additional factors within yeast or for its proper intracellular targeting. Determining whether a genetically engineered 45-kDa NMT could rescue the inviable Nmt-phenotype of S. cerevisiae (18) should permit us to address these questions. Since E. coli-derived NMT has kinetic properties similar to yeast-derived NMT, we can conclude that the enzyme's peptide and fatty acyl-CoA substrate specificities are not dependent upon either a eukaryotic protein modification or additional yeast specific factors.
Reconstitution of Protein N-myristolation in E. coli. The data in Table 1 indicated that expression of yeast NMT in E. coli yielded an enzyme that was properly folded in that its substrate specificities were largely indistinguishable from those of NMT isolated from S. cerevisiae. Since there is no endogenous NMT activity in E. coli, our results raised the possibility that coexpression of yeast NMT and a eukaryotic protein substrate in this bacterium would permit us to reproduce in a prokaryote a protein modification that is apparently exclusively eukaryotic.
PK-A was one of the earliest protein kinases to be discovered and is also one ofthe best understood biochemically (27) . The kinase is involved in the regulation of cell growth and metabolism, and its C subunit was the first protein shown to be N-myristoylated (28) . Expression of Ca cDNA (23) in E. coli led to the isolation of a soluble and active form of the protein (29) that lacked myristate at the NH2-terminal glycine. Having shown that an octapeptide derived from the NH2 terminus of the murine C subunit was a good substrate for the intact (and truncated) E. coli-derived yeast NMT in vitro (Table 1) , we decided to use the C subunit as a model protein for our in vivo reconstitution experiments. The dual plasmid system outlined in Fig. 1A was utilized to coexpress the yeast NMTJ gene and the C, cDNA. The vectors were designed so each (i) could be simultaneously maintained as a stable episomal plasmid and (ii) could support independent induction of transcription of their foreign DNA sequences. Expression of NMTJ was placed under the control of the isopropylf3-D-thiogalactopyranoside-inducible tac (30) promoter and the gJO-L ribosome binding site (20) contained in a plasmid based on pACYC177 (22) . This plasmid includes the pi5A origin of replication and a kanamycin-resistance gene. Expression of two Ca cDNAs was placed under the control of the recA promoter and glO-L present in a plasmid containing the ampicillin-resistance gene and ColEl origin ofreplication. One of these cDNAs encoded the wild-type 40-kDa C subunit of PK-A containing Gly-2, while the other produced a variant that had an Ala-2 -* Gly substitution. Note that this mutant C subunit should not be a substrate for NMT (Table 1) .
Pairwise combinations of the parental vectors and their NMTI-and Ca cDNA-containing recombinant derivatives were cotransfected into E. coli strain JM101, where they were maintained by ampicillin and kanamycin selection.
[3H]Myristate was used to label cultures of logarithmically growing cells during sequential expression of yeast NMTI followed by Ca cDNA. Lysates prepared from the cultures were subjected to SDS/PAGE and fluorography to examine radiolabeled fatty acid incorporation into protein. When the NMTJ and wild type Ca cDNA sequences were coexpressed in E. coli, a 40-kDa protein was metabolically labeled after addition of [3H]myristic acid to the culture medium (lane 4 of Fig. lb) . This protein comigrated with purified C-subunit standards. Labeling of the 40-kDa protein was absolutely dependent upon the presence of both NMTJ and wild type Ca cDNA. E. coli that expressed NMTJ but lacked C, cDNA and E. coli that lacked NMTJ but expressed Ca cDNA each failed to label the 40-kDa protein with tritiated fatty acid (lanes 6 and 7 of Fig. lb, respectively) . Moreover, the 40-kDa protein was not labeled in cells expressing NMTJ and the mutant Ca cDNA encoding the Ala-2-substituted C subunit (lane 5 of Fig. lb) . Western blot analysis with rabbit polyclonal antisera raised against the C subunit of mouse PK-A confirmed the presence of equivalent amounts of the Gly-2-and Ala-2-containing 40-kDa proteins in lysates prepared from E. coli strain JM101 with the wild-type and mutant Ca recombinant plasmids, respectively (Fig. le) . The level of production of the two C subunits was estimated to be 0.1% oftotal E. coli protein based on the signal intensities of purified C-subunit standards included in the Western blot. NMT represented -0.2% ofE. coli proteins after induction. This value was calculated from the NMT activities in crude lysates and the specific activity of purified yeast NMT (14) . Coexpression of NMTI and Ca cDNA had no deleterious effects on E. coli growth kinetics during the induction period (data not shown).
We amount of E. coli lysate proteins; and (iii) the final specific activity of [3H]myristic acid in E. colill after labeling (13 ,uCi/nmol) (33) .
Reconstitution of Protein N-myristoylation in E. con Is Specific for C14 Fatty Acids. 10-Propoxydecanoic acid (11-oxamyristic acid) is an analog of myristic acid that has a similar chain length but a reduced hydrophobicity (comparable to decanoic acid) because of the substitution of an oxygen atom for a methylene group at position 11 of the hydrocarbon chain (16) . When lO-propoxydecanoic acid is incorporated into p60vsrc in vivo, it causes a significant redistribution of the protein from membrane to cytosolic fractions (4). Metabolic labeling experiments analogous to those described above with [3H]myristic acid indicated that the C subunit could also be labeled in a Gly-2-dependent manner when exogenous 10-[3H]propoxydecanoic acid or [3H]palmitate was added to NMT-producing E. coli cells (Fig. 1 d and c, respectively) . Previous studies have suggested that palmitate must be metabolically converted to myristate before incorporation into N-myristoylated proteins (16, 31, 34 (Fig. 1 b-d, lanes 3-6) . Cells without plasmids (Fig. 1 b-d, lanes 1) or cells carrying the parental vector lacking NMTJ (Fig. 1 b- 
